Related Experiment Video
Updated: Jul 16, 2026

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy
Published on: August 25, 2019
How Well Is Blood Phenylalanine Controlled in Maternal PKU in Europe? Results from 102 Pregnancies
Alex Pinto1, Kirsten Ahring2, Manuela Ferreira Almeida3,4,5
1Birmingham Children's Hospital, Steelhouse Lane, Birmingham B4 6NH, UK.
Insights
Achieving target blood phenylalanine (Phe) levels before conception in phenylketonuria (PKU) pregnancies is challenging, though metabolic control improves during gestation. Post-pregnancy monitoring for PKU patients is often insufficient.
Area of Science:
- Metabolic disorders
- Maternal-fetal medicine
- Genetics and genomics
Background:
- High blood phenylalanine (Phe) in phenylketonuria (PKU) during pregnancy causes adverse fetal outcomes (maternal PKU syndrome).
- Strict metabolic control (Phe levels ≤ 360 µmol/L) is crucial pre-conception and throughout gestation.
- European study aimed to assess metabolic control in PKU pregnancies.
Purpose of the Study:
- To evaluate metabolic control in pregnancies affected by phenylketonuria (PKU) across multiple European centers.
- To analyze blood Phe levels, dietary intake, and monitoring frequency in PKU pregnancies.
Main Methods:
- Retrospective data collection from 11 European PKU centers (2012-2018).
- Analysis of blood Phe levels, natural protein intake, protein substitute intake, and maternal weight.
- Inclusion of 84 patients and 102 pregnancies with varying PKU classifications.
Main Results:
- Only 27% of pregnancies achieved target Phe levels ≤ 360 µmol/L pre-conception.
- During pregnancy, 88% of Phe levels were ≤360 µmol/L (mean 229 ± 65 µmol/L).
- Post-pregnancy monitoring was significantly reduced, with 25% of patients having no recorded levels.
Conclusions:
- Metabolic control during PKU pregnancies is generally good, but pre-conception control is suboptimal.
- Minimal post-pregnancy monitoring poses a risk for long-term maternal health.
- Further research is needed to understand the long-term impact on offspring.
Abstract:
Background/Objectives: In phenylketonuria (PKU), high blood phenylalanine (Phe) levels during pregnancy negatively influence foetal organogenesis and growth, leading to maternal PKU syndrome. Pregnancies must be carefully planned in order to maintain blood Phe levels ≤ 360 µmol/L pre-conception and throughout pregnancy. Our aim was to study metabolic control in PKU pregnancies across Europe. Methods: Eleven centres managing PKU participated. Data on blood Phe levels (µmol/L), natural protein intake (g/day), protein substitute intake (g/day) and maternal weight (kg) during pregnancy were collected retrospectively from dietetic records between 2012 and 2018. Results: In total, 84 female patients with PKU, accounting for 102 pregnancies (mean age: 30.4 ± 4.8 years), participated. Of these, 7 had hyperphenylalaninemia (HPA), 26 had mild PKU, 55 had classical PKU and 14 were unclassified. Sapropterin was prescribed in two pregnancies. Only 27% (28/102) of pregnancies successfully achieved consistent blood Phe levels ≤ 360 µmol/L for at least 2 weeks pre-conception. During pregnancy, 88% of blood Phe levels were ≤360 µmol/L, with a mean Phe of 229 ± 65 µmol/L. The mean number of blood Phe samples was 60 (1.5 per week) per pregnancy. In pre-pregnancy, over a mean of 2.9 years, only 35% of blood Phe levels were ≤360 µmol/L and 61% were <600 µmol/L. Post-pregnancy, over a mean of 2.8 years, 43% of Phe levels were <600 µmol/L with mean Phe 462 ± 226 µmol/L and 724 ± 230 µmol/L, respectively. 25% (25/102) had no levels performed post-pregnancy (mean of 2.8 ± 1.6 years) compared to 7% (7/102) pre-pregnancy (mean of 2.9 ± 1.5 years). Mean prescribed Phe intake pre-/during/post-pregnancy was 810 ± 721 vs. 787 ± 552 vs. 1110 ± 722 mg/day. Natural protein intake was 17 ± 15 vs. 17 ± 11 vs. 23 ± 15 g/day. Protein equivalent from protein substitute intake was 57 ± 21 vs. 66 ± 16 vs. 50 ± 23 g/day and total protein remained stable, 73 ± 14 vs. 83 ± 14 vs. 71 ± 19 g/day (1.1 ± 0.3 vs. 1.1 ± 0.4 vs. 1.0 ± 0.4 g/kg/day). Conclusions: Although a high level of metabolic control was maintained during pregnancy, fewer than 30% of pregnancies achieved constant Phe levels ≤ 360 µmol/L prior to conception, with minimal monitoring post-pregnancy. The long-term impact on the offspring remains unknown and requires further investigation.
More Related Videos
03:19Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes
Published on: June 28, 2024
09:04Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
Published on: September 10, 2018
Related Concept Videos
Inborn Errors of Metabolism
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes